on 19 Jul 2024
Last Applicant/ Owned by
Apellis Pharmaceuticals, Inc.
100 Fifth Avenue, Third FloorWaltham MA 02451
US
Serial Number
2235647 filed on 15th Dec 2022
Registration Number
TMA1245668 registered on 19th Jul 2024
Registration expiry Date
15th Dec 2032Correspondent Address
(OSLER, HOSKIN & HARCOURT LLP)BOX 501 FIRST CANADIAN PLACETORONTO
ONTARIO
CA
M5X1B8
ARCS DESIGN
Vienna Information
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
26 . 11 . 3
More than two lines or two bandsPlus de deux lignes ou de deux bandes
26 . 2 . 5
Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 2 . 7
Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses
Trademark usage description
pharmaceutical preparations, solely for human use, for the treatment of complement-mediated diseases and disorders.Classification Information
Class [005]
Pharmaceutical preparations, solely for human use, for the treatment of complement-mediated diseases and disorders.
Classification kind code
11
Mark Details
Serial Number
2235647
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 256 on 27th Nov 2023 | Notification of Possible Opposition Sent |
| Submitted for opposition 48 on 16th Aug 2023 | Agent Changed |
| Submitted for opposition 20 on 07th Aug 2023 | Examiner's First Report |
| Submitted for opposition 223 on 07th Aug 2023 | Total Provisional Refusal |
| Submitted for opposition 22 on 17th Jul 2023 | Search Recorded |
| Submitted for opposition 257 on 26th Jan 2023 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 25th Jan 2023 | Created |
| Submitted for opposition 31 on 25th Jan 2023 | Formalized |
| Submitted for opposition 228 on 15th Dec 2022 | International Registration |
| Submitted for opposition 30 on 15th Dec 2022 | Filed |